Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (22)
  • Antibiotic
    (6)
  • Antifungal
    (6)
  • MMP
    (5)
  • HIV Protease
    (3)
  • Influenza Virus
    (3)
  • Parasite
    (3)
  • Apoptosis
    (2)
  • Cytochromes P450
    (2)
  • Others
    (29)
TargetMol | Tags By ResearchField
  • Infection
    (17)
  • Cancer
    (10)
  • Immune System
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

ml 9

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    62
    TargetMol | All_Pathways
  • Peptide Products
    3
    TargetMol | Peptide_Products
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    11
    TargetMol | Natural_Products
  • Isotope Products
    8
    TargetMol | Isotope_Products
  • Reference Standards
    6
    TargetMol | Standard_Products
ML-9 Free Base
T16103110448-31-2
ML-9 (free base) suppresses MLCK, PKA, and PKC activity (Ki: 4, 32, and 54 μM, respectively). ML-9 (free base) is a selective and effective inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK), and stromal interaction molecule 1 (STIM1) acti
  • $1,520
1-2 weeks
Size
QTY
ML-9
T16104105637-50-1
ML-9 suppresses MLCK, PKA, and PKC activity with Ki values of 4, 32, and 54 μM, respectively. ML-9 is a selective and effective inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK), and stromal interaction molecule 1 (STIM1) activity. ML-9 causes autophagy by stimulating autophagosome formation and inhibiting their degradation.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
(±)9(10)-DiHOME-D4, Concentration: 100 µg/mL (Standard)
TMSM-4938
(±)9(10)-DiHOME-D4, Concentration: 100 µg/mL (Standard) is a reference standard of (±)9 (10)-DiHOME-[D4] intended for quantitative analysis, quality control, and related biochemical research applications.
  • $615
4-6 weeks
Size
QTY
(±)9,10-EpOME-D4, Concentration: 100 µg/mL (Standard)
TMSM-4937
(±)9,10-EpOME-D4, Concentration: 100 µg/mL (Standard) is a reference standard of (±)9,10-EpOME-[D4] intended for quantitative analysis, quality control, and related biochemical research applications.
  • $733
4-6 weeks
Size
QTY
Chenodeoxycholic Acid-[D9] In Methanol, Concentration: 100µg/mL (Standard)
TMSM-5557
Chenodeoxycholic Acid-[D9] (Standard) is a reference standard of Chenodeoxycholic Acid-[D9] intended for quantitative analysis, quality control, and related biochemical research applications.
  • $1,050
4-6 weeks
Size
QTY
Glycochenodeoxycholic Acid-[D9] In Methanol, Concentration: 100µg/mL (Standard)
TMSM-5564
Glycochenodeoxycholic Acid-[D9] (Standard) is a reference standard of Glycochenodeoxycholic Acid-[D9] intended for quantitative analysis, quality control, and related biochemical research applications.
  • $1,180
4-6 weeks
Size
QTY
Taurochenodeoxycholic Acid-[D9] Sodium Salt (Solution), Concentration: 100µg/mL (Standard)
TMSM-5571
Taurochenodeoxycholic Acid-[D9] Sodium Salt (Solution) (Standard) is a reference standard of Taurochenodeoxycholic Acid-[D9] Sodium Salt (Solution) intended for quantitative analysis, quality control, and related biochemical research applications.
  • $1,480
4-6 weeks
Size
QTY
18-Hydroxycorticosterone-D4 in Acetonitrile(10%Water), Concentration: 100µg/mL (Standard)
18-Hydroxycorticosterone-[D4] In Acetonitrile(10%Water) (Standard)
TMSM-56051257742-38-3
18-Hydroxycorticosterone-D4 (Standard) is a reference standard of 18-Hydroxycorticosterone-D4 intended for quantitative analysis, quality control, and related biochemical research applications. 18-Hydroxycorticosterone-d4 is a deuterated compound of 18-Hydroxycorticosterone. 18-Hydroxycorticosterone has a CAS number of 561-65-9. 18-Hydroxycorticosterone is a corticosteroid and corticosterone derivative, which can lead to serious electrolyte imbalances.
  • $1,520
7-10 days
Size
QTY
2-Hydroxyanthraquinone
T36914605-32-3
2-Hydroxyanthraquinone is an anthraquinone that has been found inSpermacoce latifoliaand has antibacterial and estrogenic activities.1,2It is active againstB. subtilisandB. cereus(MICs = 1.9 and 62.5 μg/ml, respectively).12-Hydroxyanthraquinone (19 μM) induces estrogen receptor α (ERα) activation in a yeast two-hybrid assay.2 1.Luo, Y., Shen, H.-Y., Shen, Q.-X., et al.A new anthraquinone and a new naphthoquinone from the whole plant of Spermacoce latifoliJ. Asian Nat. Prod. Res.19(9)869-876(2017) 2.Kurihara, R., Shiraishi, F., Tanaka, N., et al.Presence and estrogenicity of anthracene derivatives in coastal Japanese watersEnviron. Toxicol. Chem.24(8)1984-1993(2005)
  • $29
In Stock
Size
QTY
CYP51-IN-9
T2014461155361-07-1
CYP51-IN-9 (compound 1i) is an analog of Fluconazole and serves as an effective antifungal agent. It exhibits a MIC80 of 62.5 ng/mL against Microsporum gypseum and Candida albicans, indicating potent inhibitory activity.
  • Inquiry Price
10-14 weeks
Size
QTY
Antiviral agent 65
T2033961004319-61-2
Antiviralagent 65 (compound 9) is an antiviral agent targeting the H1N1 influenza virus, with an EC50 of 7 μg/mL.
  • Inquiry Price
10-14 weeks
Size
QTY
InhA-IN-9
T205691
InhA-IN-9 (compound 7h) is an inhibitor of the Mycobacterium tuberculosis enzyme InhA (an enoyl ACP reductase). It has the ability to bind with InhA and demonstrates anti-tuberculosis activity with a MIC value of 2 μg/mL.
  • Inquiry Price
Inquiry
Size
QTY
ROS inducer 9
T2069283081689-97-3
ROS inducer 9 (compound 4e) is an antibacterial agent with a minimum inhibitory concentration (MIC) of 0.25 μg/mL against Escherichia coli. It eradicates bacteria by inhibiting GSH activity and increasing ROS levels. Additionally, ROS inducer 9 exhibits low toxicity toward red blood cells and RAW 264.7 cells.
  • Inquiry Price
10-14 weeks
Size
QTY
Succinate dehydrogenase-IN-9
T207231
Succinate dehydrogenase-IN-9 (Compound Iik) is an inhibitor of succinate dehydrogenase with an IC50 of 3.6 μM. It demonstrates strong inhibitory activity against various fungi, such as S. sclerotiorum, with an EC50 of 1.14 μg/mL. Additionally, Succinate dehydrogenase-IN-9 enhances nitrate reductase activity, promoting plant growth.
  • Inquiry Price
Inquiry
Size
QTY
3-O-methyl Estradiol
Estradiol 3-methyl ether | 3-Methoxyestradiol | 3-O-methyl E2 | NSC 58851
T2077701035-77-4
3-O-methyl Estradiol is a synthetic estrogen known for its ability to interfere with microtubule networks in V79 Chinese hamster cells, with an EC50 value of 9 µM. At a concentration of 20 µM, it inhibits the proliferation of these cells by 92%. Additionally, when male rats on a high-cholesterol diet are administered 3-O-methyl Estradiol (25 mg in a 0.2 ml solution, p.o.), it results in decreased serum cholesterol levels and increases body weight loss, suggesting feminizing effects. It has also been utilized as a standard for quantifying 17β-estradiol in hen urine.
  • Inquiry Price
10-14 weeks
Size
QTY
Anti-MRSA agent 9
T208841
Anti-MRSA agent 9 (compound 39) exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) isolated from clinical samples, with a minimum inhibitory concentration (MIC) of 1 μg/ml. Additionally, Anti-MRSA agent 9 demonstrates anti-MRSA efficacy in vivo.
  • Inquiry Price
Inquiry
Size
QTY
AR Degrader-1
T209877
AR Degrader-1 (Compound ML 2-9) is a monovalent degrader of androgen receptors (AR) categorized under molecular glues. In LNCaP prostate cancer cells, it facilitates AR degradation through DCAF16 (E3 ligase) while exhibiting minimal cytotoxicity.
  • Inquiry Price
Inquiry
Size
QTY
Antibiofilm agent-7
T209979
Antibiofilm agent-7 (Compound 9) demonstrates significant antibiofilm activity with IC50 values of 60 µg/mL, 133.32 µg/mL, and 19.67 µg/mL against Staphylococcus aureus, Escherichia coli, and methicillin-resistant Staphylococcus aureus (MRSA), respectively. It also exhibits antimicrobial activity with MIC values of 4.88 µg/mL, 78.13 µg/mL, 9.77 µg/mL, and 39.06 µg/mL against Staphylococcus aureus, Escherichia coli, Candida albicans, and MRSA, respectively.
  • Inquiry Price
Inquiry
Size
QTY
MMP-9-IN-11
T210861
MMP-9-IN-11 (compound 77) is a potent MMP-9 inhibitor. It exhibits significant cytotoxic activity against A549 and L929 cell lines, with IC50 values of 4.04 and 13.97 μg/mL, respectively.
  • Inquiry Price
Inquiry
Size
QTY
Antileishmanial agent-34
T212343139276-16-7
Antileishmanial agent-34 (Fig. (9), compound 3) is an aurone with activity against Leishmania parasites. It is effective against extracellular forms Lmaj, Ldon, Linf, and Lenr, as well as the intracellular form of Ldon (IC50 < 2 µg/mL).
  • Inquiry Price
10-14 weeks
Size
QTY
Pradefovir
Remofovir, MB-6866, MB-06866, ICN-2001-3, ICN-20013
T28449625095-60-5
Pradefovir (Remofovir) is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection. Pradefovir is also a liver-targeted prodrug of adefovir. After metabolic activation, Pradefovir was converted to PMEA (9-(2-phosphonylmethoxyethyl)adenine) in human liver microsomes with a K(m) of 60 microM, a maximum rate of metabolism of 228 pmol/min/mg protein, and an intrinsic clearance of about 359 ml/min.
  • $238
In Stock
Size
QTY
(+)-δ-Cadinene
T35409483-76-1
(+)-δ-Cadinene is a sesquiterpene from G. hirsutum with antibacterial, insecticidal, anticancer and antiproliferative activities. It showed a MIC value of 31.25 μg/ml against S. pneumoniae and LC50s values of 8.23, 9. 2 and 3 against third instar larvae of A. stephensi, A. aegypti and C. quinquefasciatust, respectively.(+)-δ-Cadinene (10, 50 and 100 μM) induced apoptosis and inhibited the growth of OVCAR-3 human ovarian cancer cells apoptosis and inhibited their proliferation.
  • $38
Inquiry
Size
QTY
7-oxo Staurosporine
T35423125035-83-8
7-oxo Staurosporine is an antibiotic originally isolated from S. platensis with diverse biological activites. It inhibits PKC, PKA, phosphorylase kinase, EGFR, and c-Src in vitro (IC50s = 9, 26, 5, 200, and 800 nM, respectively). 7-oxo Staurosporine induces cell cycle arrest in the G2/M phase in human leukemia K562 cells with a minimal effective dose (MED) of 30 ng/ml. It is cytotoxic to P388 mouse leukemia cells that are resistant and susceptible to doxorubicin . 7-oxo Staurosporine inhibits growth of the mycelial, but not yeast form of C. albicans, C. krusei, C. tropicalis, and C. lusitaniae (MICs = 3.1-25 μg/ml). It increases sphingomyelin synthesis in CHO-K1 cells when used at a concentration of 50 nM.
  • $793
35 days
Size
QTY
β-Defensin-1 (human) (trifluoroacetate salt)
T35426
β-Defensin-1 is a peptide with antimicrobial properties that protects the skin and mucosal membranes of the respiratory, genitourinary, and gastrointestinal tracts.1It inhibits the growth ofB. adolescentis,L. acidophilus,B. breve,B. vulgatus,L. fermentum,B. longum, andS. thermophilusin an antimicrobial radial diffusion assay.2β-Defensin-1 also inhibits the growth of periodontopathogenic and cariogenic bacteria, includingP. gingivalisandS. salivarius, and of susceptibleM. tuberculosisH37Rv but not of resistantM. tuberculosisRM22 when used at a concentration of 128 μg/ml.3,4It blocks human and mouse Kv1.3 voltage-gated potassium channels (IC50s = 11.8 and 13.2 μM, respectively).5Overexpression of β-defensin-1 in the human oral squamous cell carcinoma (OSCC) cell lines HSC-3, UM-1, and SCC-9 increases migration and invasion but not proliferation.6 1.Lehrer, R.I.Primate defensinsNat. Rev. Microbiol.2(9)727-738(2004) 2.Schroeder, B.O., Ehmann, D., Precht, J.C., et al.Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptideMucosal Immunol.8(3)661-671(2015) 3.Ouhara, K., Komatsuzawa, H., Yamada, S., et al.Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cellsJ. Antimicrob. Chemother.55(6)888-896(2005) 4.Fattorini, L., Gennaro, R., Zanetti, M., et al.In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosisPeptides25(7)1075-1077(2004) 5.Feng, J., Xie, Z., Yang, W., et al.Human beta-defensin 1, a new animal toxin-like blocker of potassium channelToxicon113(2016) 6.Han, Q., Wang, R., Sun, C., et al.Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patientsPLoS One9(3)e91867(2014)
  • $1,290
35 days
Size
QTY